Advances in Monoclonal Antibody Purification - New technologies and adaptations of existing technologies can improve platform processes. - BioPharm International

ADVERTISEMENT

Advances in Monoclonal Antibody Purification
New technologies and adaptations of existing technologies can improve platform processes.


BioPharm International Supplements


References

1. Cordoba-Rodriguez RV. Aggregates in MAbs and recombinant therapeutic proteins: a regulatory perspective. BioPharm Int 2008;21(11):44–53.

2. Fahrner RL, Knudsen HL, Basey CD, Galan W, Feuerhelm D, Vanderlaan M, et al. Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography processes. Biotechnol Genet Eng Rev. 2001;18:301–27.

3. Kelley B. Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Progr. 2007;23(5):995–1008.

4. Walsh G. Biopharmaceutical benchmarks 2006. Nat Biotechnol. 2006;24(7):769–76.

5. Low D, O'Leary R. Pujar NS. Future of antibody purification. J Chrom B, 2007;848(1):48–63.

6. Farid, S. Process economic drivers in industrial monoclonal antibody manufacture. In: Gottschalk U, editor. Process scale purification of antibodies. Hoboken, NJ: John Wiley & Sons; 2009. p. 239–62.

7. Zhou JX, Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog. 2006;22(2):341–9.

8. Boi C. Membrane adsorbers as purification tools for monoclonal antibody purification. J Chrom B. 2007;848(1):19–27.

9. Gottschlich N, Kasche V. Purification of monoclonal antibodies by simulated moving-bed chromatography. J Chrom A. 1997;765(2):201–6.

10. Strohlein G, Aumann L, Muller-Spath T. Morbidelli M. The multicolumn countercurrent solvent fradient purification process. BioPharm Int. 2007 Feb supplement, Advances in Process Chromatography;42–8.

11. Muller-Spath T, Aumann L, Strohlein G. Chromatographic separation of three monoclonal antibody variants using multicolumn countercurrent solvent gradient purification (MCSGP). Biotechnol Bioeng. 2008;100(6):1166–77.

12. Przybycien TM, Pujar NS, Steele LM. Alternative bioseparation operations: life beyond packed-bed chromatography. Curr Opin Biotech. 2004;15(5):469–78.

13. McDonald P, Victa C, Carter-Franklin JN, Fahrner R. Selective antibody precipitation using polyelectrolytes: A novel approach to the purification of monoclonal antibodies Biotech Bioeng. 2009;102(4):1141–51.

14. Giese, G. Polyethylene glycol precipitation of monoclonal antibodies and the impact on column chromatography. Presented at BioProcess International Conference 2009.

15. Glynn, J. Process-scale precipitation of impurities in mammalian cell culture broth. In: Gottschalk U, editor. Process scale purification of antibodies. Hoboken, NJ: John Wiley & Sons; 2009. p. 309–24.

16. Wang J, Diehl T, Aguiar D, Dai XP, Arunakumari A. BioPharm Int. 2009 Jan Supplement, Vaccine Development and Manufacturing: Pandemics and Beyond;22(10):4–10.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
April 10, 2014
Merck Announes Management Changes
April 7, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here